USX:TARS - Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2018 Q4	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	55.45M 65.9%	56.69M 2.2%	57.03M 0.6%	24.13M -57.7%	17.39M -27.9%	16.15M -7.1%	25.82M 59.8%	27.78M 7.6%	12.5M -55.0%	14.37M 15.0%	17.45M 21.4%	42.56M 143.9%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	737K -43.2%	65K -91.2%	2.08M 3092.3%	811K -60.9%	596K -26.5%	531K -10.9%	955K 79.8%	922K -3.5%	400K -56.6%	777K 94.3%	1.59M 105.0%	3.25M 103.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	21.28M -33.8%	1.18M -94.5%	54.95M 4576.8%	23.32M -57.6%	16.8M -28.0%	15.62M -7.0%	24.86M 59.1%	26.86M 8.0%	12.1M -54.9%	13.59M 12.3%	15.85M 16.6%	39.31M 148.0%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	59.07M 24.1%	65.88M 11.5%	69.18M 5.0%	66.53M -3.8%	72.29M 8.7%	78.25M 8.2%	88.53M 13.1%	95.92M 8.3%	108.24M 12.8%	128.14M 18.4%	160.6M 25.3%	198.45M 23.6%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	57.04M 23.2%	63.78M 11.8%	67.11M 5.2%	65.72M -2.1%	71.7M 9.1%	77.72M 8.4%	87.57M 12.7%	95M 8.5%	107.84M 13.5%	127.36M 18.1%	159.01M 24.8%	195.2M 22.8%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-3.62M -	-9.19M -	-12.16M -	-42.39M -	-54.9M -	-62.1M -	-62.71M -	-68.14M -	-95.74M -	-113.77M -	-143.16M -	-155.89M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-4.88M -	-10.44M -	-13.83M -	-44.44M -	-56.53M -	-63.34M -	-62.09M -	-65.27M -	-90.95M -	-107.59M -	-135.89M -	-148.21M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-5.02M -	-10.44M -	-13.83M -	-44.35M -	-56.4M -	-63.34M -	-62.09M -	-65.27M -	-90.95M -	-107.59M -	-135.89M -	-148.21M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.244 -	-0.505 -	-0.67 -	-2.16 -	-2.63 -	-2.75 -	-2.52 -	-2.42 -	-3.42 -	-3.84 -	-4.62 -	-4.75 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.244 -	-0.505 -	-0.67 -	-2.16 -	-2.63 -	-2.75 -	-2.52 -	-2.42 -	-3.42 -	-3.84 -	-4.62 -	-4.75 -